---
created: 2025-04-13
updated: 2025-04-13T10:53
id: K&[U*oU=;[
specialty: immuno
specialty_id: 137
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::03-immune-responses::08-interferons
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::03-immune-responses::08-interferons::ifn-a
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::03-immune-responses::08-interferons::ifn-b
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::immunology-&-biochemistry-pharmacology::immuno-stimulants-&-biochemistry-pharmacology::immunostimulants-(interferons,cytokine-therapy)
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary"
type: flashcard
---

# Question
When viruses enter cells, they can trigger the host (via capsule / viral products) to produce Type I Interferons by activation of cytosolic **pattern recognition receptors**

---

# Answer
These include some Toll Like Receptors (TLR), RIG-I, and MDA5